Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS42000992
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS42000992
Fusion event
EBV-TMEM120B integration
Validated
No
Detection method
GenCap Enrichment+NGS
Data source
Curated
Sample type
Tumor
Disease
Gastric carcinoma (GC)
Quality evaluation
Normal
Reported year
2015
PubMed ID
25355872
Virus Sequence
Virus name
EBV
Reference genome
NC007605
Start
70684
Orient
-
Integrated sequence
AGGGAGCTTAGCGTGCCAGGGTTGTAATTCTTGATGTAGTGGCCCAGGAATTCAACTTCATCGTGTCTCCGTCTGCAGTTGGCGTTAATGTAGGCTGGGG| |CTACTGCCGCATATGCTGCCAAGAGACAGAGGGGCTGCTTCACATATGAGCTGCTCAGGGTCTCCACCACCTTGTTTTGACGGGCCGTGGCACAGGTGAT
Host Sequence
Chromosome
chr12
Cytoband
q24.31
Reference genome
GRCh37/hg19
Start
122186009/121748103 (Hg38)
End
122186009/121748103 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA12E
Target gene
TMEM120B
miRNAs that regulate target gene
hsa-mir-877-3p
;
hsa-mir-766-3p
;
hsa-mir-331-3p
;
hsa-mir-30c-5p
;
hsa-mir-4326
;
hsa-mir-1273g-3p
;
hsa-mir-6516-5p
;
hsa-mir-592
;
hsa-mir-455-3p
;
hsa-mir-7703
;
hsa-mir-597-5p
;
hsa-mir-668-3p
;
hsa-mir-6499-3p
;
hsa-mir-4487
;
hsa-mir-558
;
hsa-mir-3160-3p
;
hsa-mir-5186
;
hsa-mir-4793-3p
;
hsa-mir-6890-3p
;
hsa-mir-508-5p
;
hsa-mir-3149
;
hsa-mir-411-5p
;
hsa-mir-4775
;
hsa-mir-4735-5p
;
hsa-mir-590-3p
;
hsa-mir-2053
;
hsa-mir-6879-3p
;
hsa-mir-4524a-3p
;
hsa-mir-6773-3p
;
hsa-mir-215-3p
;
hsa-mir-6812-3p
;
hsa-mir-500b-3p
;
hsa-mir-4524b-3p
;
hsa-mir-1182
;
hsa-mir-6895-5p
;
hsa-mir-4755-3p
;
hsa-mir-342-3p
;
hsa-mir-4673
;
hsa-mir-4645-5p
;
hsa-mir-5693
;
hsa-mir-4650-5p
;
hsa-mir-1972
;
hsa-mir-6715b-5p
;
hsa-mir-4269
;
hsa-mir-3681-3p
;
hsa-mir-216a-3p
;
hsa-mir-128-3p
;
hsa-mir-1228-3p
;
hsa-mir-5582-5p
;
hsa-mir-34a-3p
;
hsa-mir-7977
;
hsa-mir-4738-5p
;
hsa-mir-4674
;
hsa-mir-4437
;
hsa-mir-6778-3p
;
hsa-mir-378g
;
hsa-mir-6850-3p
;
hsa-mir-4740-3p
;
hsa-mir-22-3p
;
hsa-mir-6513-5p
;
hsa-mir-887-5p
;
hsa-mir-3913-5p
;
hsa-mir-3122
;
hsa-mir-450a-1-3p
;
hsa-mir-6780a-5p
;
hsa-mir-6779-5p
;
hsa-mir-3689c
;
hsa-mir-3689b-3p
;
hsa-mir-3689a-3p
;
hsa-mir-30b-3p
;
hsa-mir-1273h-5p
;
hsa-mir-6788-5p
;
hsa-mir-30c-2-3p
;
hsa-mir-30c-1-3p
;
hsa-mir-6799-5p
;
hsa-mir-6883-5p
;
hsa-mir-6785-5p
;
hsa-mir-4728-5p
;
hsa-mir-149-3p
;
hsa-mir-7106-5p
;
hsa-mir-4767
;
hsa-mir-6087
;
hsa-mir-6089
;
hsa-mir-383-3p
;
hsa-mir-129-5p
;
hsa-mir-4298
;
hsa-mir-1302
;
hsa-mir-4314
;
hsa-mir-6716-5p
;
hsa-mir-6506-5p
;
hsa-mir-619-5p
;
hsa-mir-3192-5p
;
hsa-mir-4646-5p
;
hsa-mir-204-3p
;
hsa-mir-4797-5p
;
hsa-mir-194-5p
;
hsa-mir-555
;
hsa-mir-6512-3p
;
hsa-mir-661
;
hsa-mir-6720-5p
;
hsa-mir-6742-3p
;
hsa-mir-6849-3p
;
hsa-mir-6861-5p
;
hsa-mir-143-5p
;
hsa-mir-3155a
;
hsa-mir-3155b
;
hsa-mir-4743-3p
;
hsa-mir-4778-5p
;
hsa-mir-484
;
hsa-mir-510-5p
;
hsa-mir-5586-3p
;
hsa-mir-6758-3p
;
hsa-mir-6888-3p
Nearest miRNA
hsa-let-7i/Upstream/303751; hsa-mir-3612/Downstream/947804;
Nearest TSS
ENST00000382841/Upstream/4480;
ENST00000540377/Downstream/4026;
Nearest CpG islands
None/Target,
chr12-CpG: 104/Upstream/34918
,
chr12-CpG: 132/Downstream/44894
Upstream sequence
ctgtctccagagtcacatagcatcacttgtatggcaccctgctggtcaaagtcctcataagcccacccagattgaatgggaagggacatagaccccactt
Downstream sequence
cttggtgggaagaatgacaagatgacattgtagaagagcttgtggcatgggacgcggtatgctgctatctttaaaaaatgcaatgtgccacatgcagaaa
Reference
Cao, S., et al.High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project. J Virol,2015, 89(1): 713-729.
Sample Information
×
Sample name
GCT015
Sample type
Tumor
Gender
Female
CpG Island Information
×
Download
Curate